Neonatal and Maternal Complications of Placenta Praevia and Its Risk Factors in Tikur Anbessa Specialized and Gandhi Memorial Hospitals: Unmatched Case-Control Study

listen audio

Study Justification:
– Placenta praevia is a significant disorder during pregnancy that can lead to maternal and neonatal complications.
– The incidence of placenta praevia is increasing due to rising caesarean section rates.
– Understanding the risk factors and complications associated with placenta praevia is crucial for effective management and prevention.
Study Highlights:
– The study included 303 pregnancies complicated by placenta praevia, with a magnitude of 0.7%.
– Risk factors associated with placenta praevia included advanced maternal age (≥35), multiparity, and previous history of caesarean section.
– Maternal complications associated with placenta praevia included postpartum anemia and the need for blood transfusion.
– Neonates born to women with placenta praevia were at increased risk of respiratory distress syndrome, intrauterine growth restriction, and preterm birth.
Recommendations for Lay Reader:
– Pregnant women should be aware of the risk factors for placenta praevia, such as advanced maternal age, multiparity, and previous caesarean section.
– Women diagnosed with placenta praevia should receive appropriate monitoring and management to prevent complications.
– Neonates born to women with placenta praevia should receive specialized care to address the increased risk of respiratory distress syndrome, intrauterine growth restriction, and preterm birth.
Recommendations for Policy Maker:
– Develop and implement educational programs to raise awareness among pregnant women about the risk factors and complications of placenta praevia.
– Improve access to prenatal care and screening services to identify and manage placenta praevia cases.
– Strengthen healthcare facilities to provide specialized care for women with placenta praevia and their neonates.
Key Role Players:
– Obstetricians and gynecologists
– Midwives and nurses
– Neonatologists and pediatricians
– Public health officials
– Policy makers and government representatives
Cost Items for Planning Recommendations:
– Training and capacity building for healthcare professionals
– Development and distribution of educational materials
– Equipment and supplies for prenatal care and screening
– Upgrading healthcare facilities to provide specialized care
– Monitoring and evaluation of program implementation

Background. Placenta praevia is a disorder that happens during pregnancy when the placenta is abnormally placed in the lower uterine segment, which at times covers the cervix. The incidence of placenta praevia is 3-5 per 1000 pregnancies worldwide and is still rising because of increasing caesarean section rates. Objective. To assess and identify the risk factors and maternal and neonatal complications associated with placenta praevia. Method and Materials. Target populations for this study were all women diagnosed with placenta praevia transvaginally or transabdominally either during the second and third trimesters of pregnancy or intraoperatively in Tikur Anbessa Specialized and Gandhi Memorial Hospitals. The study design was unmatched case-control study. Data was carefully extracted from medical records, reviewed, and analyzed. Unconditional logistic regression analysis was performed using adjusted odds ratios (AOR) with 95% confidence intervals. Results. Pregnancies complicated by placenta praevia were 303. Six neonatal deaths were recorded in this study. The magnitude of placenta praevia observed was 0.7%. Advanced maternal age (≥35) (AOR 6.3; 95% CI: 3.20, 12.51), multiparity (AOR 2.2; 95% CI: 1.46, 3.46), and previous history of caesarean section (AOR 2.7; 95% CI: 1.64, 4.58) had an increased odds of placenta praevia. Postpartum anemia (AOR 14.6; 95% CI: 6.48, 32.87) and blood transfusion 1-3 units (AOR 2.7; 95% CI: 1.10, 6.53) were major maternal complications associated with placenta praevia. Neonates born to women with placenta praevia were at increased risk of respiratory syndrome (AOR 4; 95% CI: 1.24, 13.85), IUGR (AOR 6.3; 95% CI: 1.79, 22.38), and preterm birth (AOR 8; 95% CI: 4.91, 12.90). Conclusion. Advanced maternal age, multiparity, and previous histories of caesarean section were significantly associated risk factors of placenta praevia. Adverse maternal outcomes associated with placenta praevia were postpartum anemia and the need for blood transfusion. Neonates born from placenta praevia women were also at risk of being born preterm, intrauterine growth restriction, and respiratory distress syndrome.

The study was conducted in Addis Ababa, capital city of Ethiopia. The city lies at an altitude of 7546 feet (2300 metres). Tikur Anbessa Specialized Referral Hospital and Gandhi Memorial Hospital were selected for this study purposely based on the patient load. The data was collected from March 1 to July 30, 2018. The study design was unmatched case-control study. The source population of this study was the woman medical records in Tikur Anbessa Specialized Referral and Gandhi Memorial Hospitals from September 2015 to January 2018, whereas the study population was all the delivery medical records with singleton pregnancies complicated with placenta praevia at Tikur Anbessa Specialized Referral and Gandhi Memorial Hospitals from September 2015 to January 2018. All singleton deliveries with placenta praevia that took place at Tikur Anbessa Specialized Referral and Gandhi Memorial Hospital from September 2015 to January 2018 were selected for the study. First, all cases were identified from HMIS (Health Management Information System), and their medical registration number was used to access patient’s information. Complete birth registry records were considered for analysis. From 44342 total deliveries, a total of 303 placenta praevia cases were considered for analysis. Regarding control selection, controls were selected after proportional allocation to each year’s total number of deliveries in both hospitals. A systematic random sampling method using the patient’s medical registration number was used, and finally, 303 controls without placenta praevia were regarded for the study. (1) For cases (2) For controls Postpartum hemorrhage (PPH): defined as a blood loss of 500 ml or more within 24 hours after birth. Moderate anemia: corresponds to a hemoglobin level of 7.0-9.9 g/dl. Severe anemia: corresponds to a hemoglobin level of less than 7 g/dl. Urinary tract infection (UTI): an infection involving any part of the urinary system, including the urethra, bladder, ureters, and kidney. Intrauterine growth restriction (IUGR): refers to the poor growth of a baby while in the mother’s womb during pregnancy. Respiratory distress syndrome (RDS): the most common lung disease in premature infants and occurs because the baby’s lungs are not fully developed. Neonatal jaundice: a yellowish discoloration of the white part of the eyes and skin in a newborn baby due to high bilirubin levels. Low birth weight (LBW): defined as a birth weight of less than 2500 g (up to and including 2499 g), as per the World Health Organization. A checklist was designed to collect data about study participant’s sociodemographic characteristics, obstetric and gynecological history, history of current pregnancy, mode of delivery, and maternal and neonatal complications. Data was checked for completeness and consistency before data entry by the principal investigator; the completed questionnaire was coded. For data cleaning, the coded data was entered into EPI Info version 3.5. Data was entered into EPI Info version 3.5.1 for data exploration and cleaning. The cleaned data was exported to SPSS version 25 for statistical analysis. Descriptive statistics was used to summarize categorical variables. Both bivariate and multivariable analyses were performed using logistic regression and adjusted odds ratios (AOR) with 95% confidence intervals for risk factors and maternal and neonatal complications associated with placenta praevia. P value < 0.05 was considered statistically significant. Ethical clearance for the proposed study was obtained from Addis Ababa University Institute of Review Board and Addis Ababa Health Bureau. Data was collected from patients' medical record, and confidentiality of the information was maintained throughout by excluding names as identification in the study.

N/A

Based on the information provided, here are some potential innovations that can be used to improve access to maternal health:

1. Telemedicine: Implementing telemedicine services can allow pregnant women in remote or underserved areas to access prenatal care and consultations with healthcare providers without the need for physical travel.

2. Mobile health (mHealth) applications: Developing mobile applications that provide educational resources, appointment reminders, and personalized health information can empower pregnant women to take an active role in their own healthcare and improve access to information.

3. Community health workers: Training and deploying community health workers who can provide basic prenatal care, education, and support to pregnant women in their communities can help bridge the gap in access to maternal health services, especially in rural or marginalized areas.

4. Transportation services: Establishing transportation services specifically for pregnant women, especially those living in remote areas, can ensure that they have access to timely and safe transportation to healthcare facilities for prenatal care, delivery, and postnatal care.

5. Health education campaigns: Conducting targeted health education campaigns to raise awareness about the importance of prenatal care, early detection of complications, and the availability of maternal health services can help overcome barriers to accessing care and encourage women to seek timely healthcare.

6. Maternal health clinics: Setting up dedicated maternal health clinics in areas with high maternal mortality rates can provide comprehensive prenatal, delivery, and postnatal care services in one location, making it easier for women to access the care they need.

7. Public-private partnerships: Collaborating with private healthcare providers and organizations to expand access to maternal health services can help increase the availability of quality care, especially in areas where public healthcare facilities are limited.

8. Financial incentives: Implementing financial incentives, such as subsidies or cash transfers, for pregnant women to seek prenatal care and deliver in healthcare facilities can help reduce financial barriers and improve access to maternal health services.

It’s important to note that the specific context and resources available in each setting will influence the feasibility and effectiveness of these innovations.
AI Innovations Description
Based on the information provided, here is a recommendation that can be developed into an innovation to improve access to maternal health:

1. Implement a comprehensive screening program: Develop a screening program to identify pregnant women at risk of placenta praevia. This program should be implemented in healthcare facilities, particularly in areas with a high prevalence of placenta praevia. The screening program should include regular ultrasound examinations during the second and third trimesters of pregnancy to detect placenta praevia early on.

2. Increase awareness and education: Conduct educational campaigns to raise awareness among pregnant women and healthcare providers about the risk factors and complications associated with placenta praevia. This can be done through community outreach programs, antenatal care sessions, and online platforms. The goal is to ensure that women are informed about the condition and its potential risks, enabling them to seek appropriate care and treatment.

3. Strengthen healthcare infrastructure: Improve the capacity of healthcare facilities, particularly in areas with a high prevalence of placenta praevia, to handle cases of placenta praevia and its complications. This includes ensuring the availability of skilled healthcare providers, necessary equipment, and blood transfusion services to manage maternal and neonatal complications associated with placenta praevia.

4. Enhance referral systems: Establish effective referral systems between primary healthcare centers and specialized hospitals to ensure timely access to appropriate care for pregnant women with placenta praevia. This includes developing protocols for transferring high-risk cases to specialized facilities equipped to handle complications related to placenta praevia.

5. Conduct further research: Encourage further research on placenta praevia, its risk factors, and associated complications to improve understanding and inform evidence-based interventions. This can help identify additional strategies to prevent and manage placenta praevia, ultimately improving maternal and neonatal outcomes.

By implementing these recommendations, it is possible to develop innovative approaches to improve access to maternal health and reduce the burden of placenta praevia and its associated complications.
AI Innovations Methodology
To improve access to maternal health, here are some potential recommendations:

1. Telemedicine: Implementing telemedicine services can provide remote access to healthcare professionals for prenatal care, consultations, and postpartum support. This can be especially beneficial for women in rural or underserved areas who may have limited access to healthcare facilities.

2. Mobile health (mHealth) applications: Developing mobile applications that provide educational resources, appointment reminders, and personalized health information can empower pregnant women to take control of their own health and access necessary care.

3. Community health workers: Training and deploying community health workers can help bridge the gap between healthcare facilities and pregnant women in remote areas. These workers can provide education, support, and referrals to ensure women receive appropriate care throughout their pregnancy.

4. Transportation services: Establishing transportation services specifically for pregnant women can help overcome geographical barriers and ensure timely access to healthcare facilities for prenatal visits, delivery, and emergency care.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the target population: Identify the specific population that will benefit from the recommendations, such as pregnant women in rural areas or low-income communities.

2. Collect baseline data: Gather information on the current state of access to maternal health services in the target population, including factors like distance to healthcare facilities, availability of transportation, and utilization of prenatal care.

3. Develop a simulation model: Create a model that incorporates the potential impact of the recommendations on improving access to maternal health. This could involve factors such as the number of telemedicine consultations, the increase in prenatal care visits due to mobile health applications, or the number of community health workers deployed.

4. Input data and run simulations: Input the baseline data into the simulation model and run multiple simulations to estimate the potential impact of the recommendations. Adjust the parameters of the recommendations, such as the number of telemedicine consultations or the coverage of community health workers, to explore different scenarios.

5. Analyze results: Analyze the results of the simulations to determine the projected improvements in access to maternal health services. This could include metrics such as increased utilization of prenatal care, reduced travel time to healthcare facilities, or improved health outcomes for mothers and infants.

6. Validate the model: Validate the simulation model by comparing the projected results with real-world data or conducting pilot studies to assess the actual impact of implementing the recommendations.

By following this methodology, policymakers and healthcare providers can gain insights into the potential benefits of implementing innovative solutions to improve access to maternal health and make informed decisions on resource allocation and implementation strategies.

Partilhar isto:
Facebook
Twitter
LinkedIn
WhatsApp
Email